Vraylar 4.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FS6BM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,194
Award facts
- Contract value 100% obligated
- $26,193.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 4.5 mg capsules (30-count units) under a firm fixed price contract valued at $26,193.62. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability across multiple therapeutic domains through its extensive federal contract portfolio with the Defense Logistics Agency and other federal healthcare systems. The Vraylar supply supports military and veteran healthcare needs, with the delivery order reflecting the company's role as a critical vendor for federal medical procurement. The DLA Troop Support is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving defense and federal healthcare customers through an expanded, flexible contracting framework.
Quick answers
Who was awarded contract SPE2DB25FS6BM?
SPE2DB25FS6BM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FS6BM worth?
The government has obligated $26,194 on SPE2DB25FS6BM.
Is contract SPE2DB25FS6BM an order under another contract?
Yes. SPE2DB25FS6BM is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6BM competed?
The extent of competition for SPE2DB25FS6BM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award